Grindeks AS logo

GRD1R - Grindeks AS Share Price

€11.8 0.6  5.4%

Last Trade - 2:30pm

Sector
Healthcare
Size
Small Cap
Market Cap £95.1m
Enterprise Value £116.8m
Revenue £126.6m
Position in Universe 158th / 745
Bullish
Bearish
Unlock GRD1R Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

GRD1R Revenue Unlock GRD1R Revenue

Net Income

GRD1R Net Income Unlock GRD1R Revenue

Normalised EPS

GRD1R Normalised EPS Unlock GRD1R Revenue

PE Ratio Range

GRD1R PE Ratio Range Unlock GRD1R Revenue

Dividend Yield Range

GRD1R Dividend Yield Range Unlock GRD1R Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
GRD1R EPS Forecasts Unlock GRD1R Revenue
Profile Summary

Grindeks AS (Grindeks JSC) is a Latvia-based joint stock company engaged in the pharmaceutical sector. The Company is engaged in the production of pharmaceutical and medical products, and phytochemical medicine. The Company offers products, such as: ointments, cough and cold medications, anti-inflammatory agents, gastroenterological agents, tonics and natural health products, as well as active pharmaceutical substances. The Company’s research activities are mainly focused towards the development of cardiovascular medications, neurological medications, anti cancer agents and antiviral drugs. The Company is active domestically and abroad, mainly in the Commonwealth of Independent State countries. It also owns four subsidiaries, Tallin Pharmaceutical Plant JSC, Namu Apsaimniekosanas projekti Ltd, Grindeks RUS Ltd and Kalceks JSC. As of December 31, 2011, the Company’s major corporate shareholder was AB.LV Private Equity Fund 2010, with a stake of 11.38%.

Directors
Last Annual December 31st, 2018
Last Interim June 30th, 2019
Incorporated October 11, 1991
Public Since June 1, 1998
No. of Shareholders: n/a
No. of Employees: 1,422
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange OMX Baltic Exchange - Riga
Shares in Issue 9,585,000
Free Float (0.0%)
Eligible for
ISAs
SIPPs
GRD1R Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for GRD1R
Upcoming Events for GRD1R
Similar to GRD1R
© Stockopedia 2019, Thomson Reuters, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.